RE: So all the lobsters locked in this stock mustOk and what is MYG supposed to do in the coming year? i guess it's just going to behave like you, doing nothing!
It is funny that Dumbo and you, out of frustration, are always bringing up MYG here and after you scream like pigs when I talk about it. First. It is up by 400% since last December, remember "expression of interest", while since that time, TLN is only 40% up. So aleready I am a clear winner with it. Obviously, for you, MYG would have been a better choice. Unfortunately, they are not the kind of company to talk about other companies possible interest in press releases.
As for what is coming in the next year? I will tell you because you ask for it. They are likely to sign a new partnership with a good upfront payment for their HDAC inhibitor MGC0103. They will release results, probably at ASCO, of their ongoing comparative phase I/II study for their kinases inhibitor MGCD265 in combination with Tarceva and Taxotere. Then, they will choose between Tarceva and Taxotere to go forward in a phase II in Non Small Cell Lung Cancer. Remember how you thought that combo with Tarceva was a good idea for 4601. MYG are not only doing pre-clinical tests with it. They are now in the clinic.
This company is not trying to hype it's stock by making false promises and giving false hope to the market. They are very conservative in their disclosure. They work hard, and they go puclic when there is a real news. So good surprises are possible. Some insiders from the board of directors recently bought the stock to put on top of their options. Not very huge amount, but it is better than zero.
So the funny thing in the coming year is that I am likely to laugh at both of you for TLN problems, and also for MYG good news and stock price rise!!!!!! I will be winner at both ends!!!!! It is aleready funny, but more fun is to come. So stay tuned!!!!!!